v3.10.0.1
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
9 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating activities    
Net loss for the period $ (7,127,966) $ (8,436,636)
Adjustment for items not affecting cash    
Depreciation 50,190 69,606
Amortization 209,682 246,920
Interest expense 129,933 640,168
Share based compensation expense 1,226,374 1,284,257
Shares issued for services 0 60,000
Accretion expense 2,421,060 290,375
Fair value adjustment (337,923) 0
Gain on mark to market revaluation (2,048,697) 0
Allowance for doubtful accounts 6,001 (16,349)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities (5,471,346) (5,861,659)
Changes in non-cash working capital items    
Accounts receivable (1,314,380) 93,680
Prepaid expenses and other receivables (1,398,301) 83,003
Due from related parties 908 (643)
Inventories (98,163) (74,165)
Accounts payable 669,779 10,104
Accrued liabilities (429,935) 639,568
Customer advances (800) (120,762)
Deferred revenue 162,473 15,177
Net cash (used in) operating activities (7,879,765) (5,215,697)
Investing activities    
Acquisition of equipment (26,071) (17,182)
Net cash (used in) investing activities (26,071) (17,182)
Financing activities    
Proceeds from convertible loans 7,826,633 4,699,975
Proceeds on exercise of warrants 0 1,125,038
Repayment of promissory notes principal 0 (200,000)
Repayment of promissory notes interest 0 (49,505)
Repayment of demand notes principal (50,000) (208,359)
Repayment of demand notes interest (2,975) (79,259)
Proceeds from short term loan 0 400,000
Net cash provided by financing activities 7,773,658 5,687,890
Net decrease in cash and cash equivalents for the period (132,178) 455,011
Cash and cash equivalents, beginning of period 507,311 543,650
Cash and cash equivalents, end of period $ 375,133 $ 998,661

Source